image class="left" url="http://media1.picsearch.com/is?aRJJuu6aEcOJu9Eq9dxLnx5M9_IFi7Zpqgspxn9yFyo&height=224"Our attorneys have filed a mass tort lawsuit on behalf of individuals who took the blood thinner Xarelto (rivaroxaban) and suffered critical bleeding events. Pharmaceutical firms, such as the makers of Xarelto, have a duty to ensure that their drugs are reasonably safe for use - and failure to complete so may possibly be grounds for compensation. Our lawyers are functioning hard to get those hurt by the drug the compensation they're entitled to.













Whilst bleeding can be a widespread complication linked with anticoagulants, it has been alleged that Xarelto is more unsafe than conventional blood thinners since no antidote exists to reverse its blood-thinning effects. This means that, inside the occasion of an emergency, patients may possibly be at threat for irreversible bleeding problems, such as life-threatening internal and gastrointestinal hemorrhaging.













In the event you or a loved one particular suffered a serious bleeding event following taking Xarelto, you may have legal recourse. For a lot more info, contact us these days to have your case reviewed, free of charge of charge.






Compensation Possibilities













xarelto-compensation-photoThe plaintiffs in these lawsuits are seeking compensation from Bayer and Janssen for enquiry previous and future medical bills, lost wages, discomfort and suffering and, in circumstances of death, funeral expenses. Moreover, they may be searching for punitive damages, that are normally awarded to punish the defendant and deter other businesses from acting similarly.






Why Are Lawsuits Being Filed?













Bayer and Johnson & Johnson’s Janssen Pharmaceuticals, Inc. are facing several Xarelto lawsuits alleging that the drug is unsafe and defective. The plaintiffs claim that, unlike traditional anticoagulants (e.g. warfarin, Coumadin) whose blood-thinning effects can be reversed using vitamin K, there is no antidote available for Xarelto. Simply because of this, the lawsuits claim, doctors have no effective means of stopping Xarelto users from bleeding in the occasion of an emergency. Plaintiffs within the lawsuits allege serious and fatal injuries, including cerebral hemorrhaging and gastrointestinal bleeds, from use of the drug.













In addition to these risks, lawsuits against Bayer and Johnson & Johnson’s Janssen Pharmaceuticals are alleging:













The manufacturers of Xarelto marketed the drug as a superior in the field of anticoagulants despite studies finding higher rates of gastrointestinal (GI tract) bleeding and transfusions in Xarelto users than users of certain competitors.






The makers of the drug continue to market Xarelto as a safe anticoagulant option.






Doctors and medical staff were not properly made aware of methods to stabilize and treat a Xarelto user in the occasion of a bleeding complication.






Users of Xarelto were not adequately warned of the health risks of suffering a fatal bleeding event.






Xarelto is linked to critical bleeding complications, excessive blood loss, intracranial hemorrhaging, eye bleeding (vitreous hemorrhage), stomach bleeding, gastrointestinal bleeding, wound infections from inhibited clotting, and lack of effectiveness in preventing dangerous clotting.













Visit this page for a lot more data on the alleged health risks of Xarelto.






Multidistrict Litigation Trial Dates Set













The attorneys in the Complex Litigation Group have filed lawsuits on behalf of injured clients. The claims will proceed through multidistrict litigation (MDL), which currently entails four trials, scheduled for Fall 2016, in which random groups of plaintiffs will be chosen to represent the group.
There are no comments on this page.
Valid XHTML :: Valid CSS: :: Powered by WikkaWiki